Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Dalfampridine prior authorization program: a cohort study.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Treatment of multiple sclerosis in children and its challenges.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Environmental factors and multiple sclerosis severity: a descriptive study.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »